在接受免疫检查点抑制剂 (ICI) 治疗的晚期黑色素瘤患者的症状体验

Natalie Jackson-Carroll1, Constance Johnson2, Hussein Tawbi3

  • 1Cizik School of Nursing, The University of Texas Health Science Center at Houston; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

PubMed
概括

接受免疫检查点抑制剂 (ICI) 治疗晚期黑色素瘤的患者经历了各种症状和对生活质量的影响. 清晰的沟通和验证的工具可以改善患者的护理和对治疗结果的理解.